Atlas Trials

Relative Bioavailability (RBA) Study of LY03005 vs Pristiq®

Clinical trial NCT03357796 · COMPLETED

Trial details

NCT number
NCT03357796
Sponsor
Luye Pharma Group Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2017-11-27
Primary completion
2017-12-22
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.